Code | 18423 | ||||||||||
MA number | 13/0823/95-S | ||||||||||
Product Form: | sol inj 6x2 ml/6 mg (liek.inj.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Sanofi Winthrop Industrie, France | ||||||||||
Therapeutic Class: | 13 - ANTIARRYTHMICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 14.12.1995 |
SPC: | SPC_Adenocor_sol inj_10_2023.pdf |
PIL: | PIL_Adenocor_sol inj_10_2023.pdf |
Safety feature | Yes |
Data update: | 11.04.2018 |